Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | MNDA |
| Upstream (Parents) |
|---|
| (<<) CSF2RB → MNDA |
| (<<) NCF2 → MNDA |
| (<<) PTPRC → MNDA |
| (<<) CLEC7A → MNDA |
| (<<) HCK → MNDA |
| Downstream (Children) |
|---|
| MNDA → CYTIP (>>) |
| MNDA → KIAA0748 (>>) |
| MNDA → LYZ (>>) |
| MNDA → S100A8 (>>) |
| MNDA → NLRP1 (>>) |
| MNDA → KCNJ15 (>>) |
| MNDA → BIN2 (>>) |
| MNDA → TNFRSF10C (>>) |
| MNDA → FAM65B (>>) |
| MNDA → CCL22 (>>) |
| MNDA → RAPGEF1 (>>) |
| MNDA → S100A9 (>>) |
| MNDA → SELL (>>) |
| MNDA → KRT18P38 (>>) |
| MNDA → FCGR3B (>>) |
| MNDA → P2RY14 (>>) |
| MNDA → CXCR2 (>>) |
| MNDA → FPR2 (>>) |
| MNDA → RGS2 (>>) |
| MNDA → SNCA (>>) |
